The hepatitis C virus (HCV) nonstructural (NS) 3 protein has been shown to possess at least two enzymatic domains. The amino terminal third contains a serine-protease domain, whereas the carboxy terminal two thirds is comprised of an adenosine triphosphatase (ATPase)/helicase domain. These domains are essential for the maturation of the carboxy-terminal portion of the HCV polyprotein and catalyze the cap synthesis of the RNA genome. In this report, human and murine antibody responses induced by NS3 were characterized using a recombinant full-length NS3 (NS3-FL) protein, or the isolated protease or ATPase/ helicase domains, expressed and purified from Escherichia coli. Sera from 40 patients with chronic HCV infection were assayed in enzyme-linked immunoassays (EIAs) for antibody binding to the panel of NS3 proteins. Virtually all patient sera contained antibodies specific for NS3-FL and the ATPase/helicase domain, whereas only 10% of sera reacted with the protease domain of NS3. Human antibodies reactive with NS3-FL were highly restricted to the immunoglobulin G1 (IgG1) isotype and were inhibited by soluble ATPase/helicase, but not by the protease domain. The anti-NS3 (ATPase/helicase) reactivity decreased on denaturation by sodium dodecyl sulfate (SDS) and -mercaptoethanol (2ME), suggesting the recognition of nonlinear or conformational B-cell determinants. Similar to infected humans, mice immunized with NS3-FL developed high-titered primary antibody responses to the NS3 ATPase/ helicase domain, whereas an anti-NS3 protease response was not observed after primary or secondary immunizations. Thus, the human and murine humoral immune responses to the HCV NS3 protein are focused on the ATPase/helicase domain, are restricted to the IgG1 isotype in humans, and are conformationally dependent. Unexpectedly, in both species, the NS3 protease domain, present in the context of the full-length NS3, appears to possess low intrinsic immunogenicity in terms of antibody production. (HEPATOLOGY 1998;28:219-224.)The hepatitis C virus (HCV) is a recent member in the virus family Flaviviridae, and has been classified as a separate genus from the pestiviruses and the flaviviruses. 1,2 The protein sequences of the three genera share short stretches of homologies that, upon comparison at the molecular level, led to the identification of the putative structural organization of the HCV polyprotein. 3,4 This was soon followed by in vitro transcriptional and translational analysis with the characterization of functional properties of the predicted viral genes. Data available today indicate that the HCV polyprotein-NH2-core (C)-envelope 1 (E1)-E2-nonstructural protein 2 (NS2)-NS3-NS4a-NS4b-NS5a-NS5b-COOH is encoded by a single positive-stranded RNA genome of approximately 9,400 nucleotides. Like other members in the family Flaviviridae, posttranslational processing of this precursor protein is required to generate the HCV viral particles and the individual viral proteins needed for its replicative cycle. The processing of the core (nucle...